Illumina

Executive Sales Specialist (Human Array) UK, Ireland & North

England, United Kingdom

Auto‑apply with AI Apply

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Life SciencesIndustries

Requirements

Candidates should possess a Bachelor's degree in a relevant field, along with a minimum of 5 years of experience in sales, preferably within the life sciences or genomics industry. Strong knowledge of the UK, Ireland, and North European markets is required, as is the ability to build and maintain relationships with key stakeholders.

Responsibilities

The Executive Sales Specialist will be responsible for protecting, expanding, and creating new human array business within the UK, Ireland, and North region, collaborating with account management and other teams to achieve revenue growth and profitability. They will develop strategic plans for winning new business, identify innovative solutions, execute campaigns, and manage customer relationships, ultimately aiming to maximize the company’s return on investment and build strong customer relationships.

Skills

Genomics

Sales

Account Management

Strategic Planning

Customer Relationship Management

Communication

Presentation

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free